Regis Technologies provides a comprehensive range of custom pharma development and manufacturing services for small molecule APIs supporting the development of lead molecules from preclinical to clinical.
In addition to its development and manufacturing services, Regis offers an innovative line of chromatography products, including its WHELK-O® 1, IAM, REFLECT™ Polysaccharide columns, and EVOKE™ C18 and CELERIS™ achiral phases, along with high purity GC and imaging reagents sold throughout th...hout the world.
Regis Custom Pharma is a US-based contract development and manufacturing organization (CDMO) focused on the development and manufacture of NCEs (New Chemical Entities). The company offers a comprehensive range of drug substance development services, including Process Chemistry, Analytical Method Development and Validation, Solid State Chemistry, Micronization, cGMP Manufacturing, Process Validation, and Stability Services.
Over the last 65 years, Regis has had a successful history of supporting the development of hundreds of new drug candidates. Many programs have entailed Process Optimization, Process Registration, and Validation. Today, the company manufactures drug substances for both clinical use and the commercial market.